https://www.selleckchem.com/pr....oducts/bay-1217389.h
Hence, NAFLD should further be addressed as a risk factor and therapeutic target for the early prevention of type 2 diabetes.Microexons are small sized (≤51 bp) exons which undergo extensive alternative splicing in neurons, microglia, embryonic stem cells, and cancer cells, giving rise to cell type specific protein isoforms. Due to their small sizes, microexons provide a unique challenge for the splicing machinery. They frequently lack exon splicer enhancers/repressors and require specialized neighboring trans-regulatory and cis-reg
Like
Comment
Share
